Meta Pixel

News and Announcements

Instarent Making Big Strides in 2020

  • Published March 02, 2020 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Instarent has achieved its partial seed funding through Birchal, further validating the demand within the market for their platform and app, with EOI of 400 Responses and 177 Investors equating to $333.796.

Instarent was also named in the Australian Financial Review as the top 6 prop-tech startups to watch 2020 stating that “More than 150 tech investors piled into a recent seed funding round for property management platform Instarent, putting more than $313,000 into the company via equity crowdfunding platform Birchal. Instarent is an app targeting the one in three property investors who self-manage their properties. It connects landlords with tenants via a digital platform that replicates many of the functions a traditional property manager would provide such as online listings, tenancy agreements and getting a tradie for repairs.”

Instarent is now looking to close their first funding round, looking to raise a further $700,000 available for potential investors.

Click here to read the Australian Financial Review Article that Instarent featured in.

 

About Instarent

Instarent’s mission is to empower landlords and tenants to self- manage property. They do this with the reinvention of the current process, moving to a paperless platform and rental property management system, built exclusively for landlords and tenants. Instarent’s objective is to even out the field and bring Australia’s first long-term property management application to all the users looking for transparency, reliability and ease of use.

Affordable property management is now within reach. They have brought together property advertising, tenancy applications and property management services into one easy application, removing the need for an agent. End to end property management, all in one easy to use app.

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now